Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus

Abstract

We studied the epidemiologic triad-related factors influencing human papilloma virus (HPV) persistence in Mexican women with systemic lupus erythematosus (SLE). Patients aged ≥18 years with SLE (American College of Rheumatology criteria), with and without HPV persistence, were selected. Groups were analyzed by (1) host: clinical disease characteristics; (2) agent: (I) infectious (prevalence, incidence, HPV genotype and co-infections (≥2 HPV genotypes or mycoplasmas)), (II) chemical (contraceptives and immunosuppressive drugs) and (III) physical (vitamin D deficiency) and (3) environment. A total of 121 SLE patients were selected over a two-year period. (1) Host: mean age 45.8 years and disease duration 12.7 years. (2) Agent: (I) infectious. HPV infection prevalence in the second sample was 26.4%, high-risk HPV genotypes 21.5% and co-infections 7.4%. HPV infection incidence was 13.2%, persistence 13.2% and clearance 15.7%. (II) Chemical: use of oral hormonal contraceptives 5% and immunosuppressive treatment 97.5%. (III) Physical: Vitamin D levels were similar in both groups. (3) Environment: (I) natural. A total of 60.6% of patients were residents of Puebla City. (II) Social: The mean education level was 10.9. Poverty levels were: III degree 52.4%, IV degree 28% and II degree 17%. (III) Cultural behavioral: Onset of sexual life was 20.5 years, 10% had ≥3 sexual partners and 51.2% were postmenopausal. In conclusion, no factor of the epidemiologic triad was associated with HPV infection prevalence.

Keywords

Epidemiologic triad systemic lupus erythematosus epidemiology HPV

Get full access to this article

View all access options for this article.

References

Smith

Melendy

Rana

Pimenta

. Age-specific prevalence of infection with human papillomavirus in females: A global review. J Adolesc Health 2008; 43(4 Suppl: S5-25, S25.e1–e41.

Saslow

Solomon

Lawson

et al.

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 2012; 16: 175–204.

Aguilar-Lemarroy

Vallejo-Ruiz

Cortés-Gutiérrez

et al.

Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: Type-specific prevalence and HPV coinfections. J Med Virol 2015; 87: 871–884.

Centers for Disease Control and Prevention. Understanding the epidemiologic triangle through infectious disease, 2012. CDC.gov. Principles of Epidemiology, Lesson 1- Section 8. [online]. 2012. Available at: https://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson1/section8.html [Accessed 6 November 2017].

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725–1725.

Guzmán

Cardiel

Arce-Salinas

Sánchez-Guerrero

Alarcón-Segovia

. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992; 19: 1551–1558.

Bhatla N, Cain J, Nahida C, et al. Global guidance for cervical cancer prevention and control [Internet]. 2009. Available at: http://www.rho.org/files/FIGO_cervical_cancer_guidelines_2009.pdf [Accesed 31 October 2017].

Biernat-Sudolska

Szostek

Rojek-Zakrzewska

Klimek

Kosz-Vnenchak

. Concomitant infections with human papillomavirus and various mycoplasma and ureaplsasma species in women with abnormal cervical cytology. Adv Med Sci 2011; 56: 299–303.

Rositch

Koshiol

Hudgens

et al.

Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis. Int J Cancer 2013; 133: 1271–1285.

10.

Skinner

Wheeler

Romanowski

et al.

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer 2016; 138: 2428–2438.

11.

García-Carrasco

Mendoza-Pinto

Ayón-Aguilar

et al.

Serum levels of vitamin D in systemic lupus erythematosus patients (SLE) and their relationship with disease activity: Longitudinal study [article in Spanish]. Gac Med Mex 2016; 152(Suppl 2): 32–37.

12.

Mendoza-Pinto

Méndez-Martínez

Soto-Santillán

et al.

Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women. Lupus 2015; 24: 1227–1232.

13.

Taheri

Baheiraei

Foroushani

Nikmanesh

Modarres

. Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: A placebo-controlled randomized clinical trial. Indian J Med Res 2015; 141: 799–806.

14.

García-Carrasco

Mendoza-Pinto

Munguía-Realpozo

et al.

Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus. Lupus 2015; 24: 606–612.

15.

Bernatsky

Fournier

Pineau

Clarke

Vinet

Smargiassi

. Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE). Environ Health Perspect 2011; 119: 45–49.